Echo Therapeutics (ECTE) Closes 3.2M Offering at 95c/Share

Go back to Echo Therapeutics (ECTE) Closes 3.2M Offering at 95c/Share

Echo Therapeutics (ECTE) Underwriters Exercise Full Overallotment in 3.2M Offering

December 26, 2012 4:19 PM EST

Echo Therapeutics, Inc. (Nasdaq: ECTE) announced the full exercise of the over-allotment option granted to the underwriters to purchase 480,000 additional common shares, at a public offering price of $0.95 per share, in connection with its previously announced underwritten public offering of 3,200,000 shares of common stock,... More

Echo Therapeutics (ECTE) Prices 3.2M Offering at 95c/Share

December 21, 2012 7:06 AM EST

Echo Therapeutics, Inc. (Nasdaq: ECTE) today announced the pricing of a previously announced underwritten public offering of 3,200,000 shares of its common stock, offered at a price to the public of $0.95 per share. The gross proceeds to Echo from this offering are expected to be approximately $3.0... More

Echo Therapeutics (ECTE) Announces Common Offering

December 20, 2012 4:26 PM EST

Echo Therapeutics, Inc. (Nasdaq: ECTE) intends to offer for sale its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be... More